Group 1 - The article discusses the trend of fund managers transitioning to roles as company secretaries in listed companies, indicating a shift beyond asset management [1][4] - Jiang Ying has been appointed as the new company secretary of Luoxin Pharmaceutical, marking a notable case of a fund manager moving into this role [2][3] - Jiang Ying has a strong academic background with dual degrees in Science and Economics from Peking University, and a Master's in Management and Finance from Hong Kong University, but lacks prior experience as a company secretary [3] Group 2 - Luoxin Pharmaceutical reported a revenue of 1.077 billion yuan for the first half of 2025, a year-on-year decrease of 14.45%, while achieving a net profit of 17.695 million yuan, indicating a turnaround from losses in the previous year [4] - The company has faced significant performance fluctuations in recent years, attributed to factors such as the COVID-19 pandemic, impairment provisions, and adjustments in financial liabilities [4] - The trend of hiring former financial professionals as company secretaries has been noted, with examples including Wang Shangbo from Hongtu Innovation Fund and Liu Haoyu from Dongwu Fund, who have transitioned to roles in listed companies [4]

【 导读 】 基金经理 转型 已 不局限在资管领域， 前国泰基金经理被聘为上市药企董秘 中国基金报记者 储是 10月13日， 罗欣药业发布关于聘任董事会秘书的公告， 显示 聘任姜英为董事会秘书。 公告未披露新任董秘姜英的 薪酬 情况， 前任董秘韩风生2024年薪酬为84.57万元 。 资料显示， 姜英 出生于 1987年，为 北京大学理学、经济学双学位本科，北京大学管理学硕 士及香港大学金融学硕士。 姜英 曾主要任职于国金证券资产管理分公司、光大保德信基金担 任分析师，于国泰基金担任分析师、基金经理助理、基金经理，无上市公司董秘工作经验。 | NEW YORK | 2 11 12 11 11 11 | | | | | | | | | --- | --- | --- | --- | --- | --- | --- | --- | --- | | 열매요이 | 代目 | 产品名称 | 特色同盟 | 田原田町 | NEED | 8000 | 年代回报 | 国际网站 | | 工作品 | 506000.01 | 国泰国际娱乐平台官 | 保障局合量 | 2002-02-18 | 2024-12-24 | -12-43% ...